Muyan Cai Selected Research

Proteins (Proteins, Gene)

12/2017	p53R2 as a novel prognostic biomarker in nasopharyngeal carcinoma.
2/2016	High expression of HEF1 predicts a poorer prognosis of hepatocellular carcinoma: A retrospective study.
10/2014	Overexpression of RFC3 is correlated with ovarian tumor development and poor prognosis.
8/2014	CYR61 overexpression associated with the development and poor prognosis of ovarian carcinoma.
3/2014	α4 contributes to bladder urothelial carcinoma cell invasion and/or metastasis via regulation of E-cadherin and is a predictor of outcome in bladder urothelial carcinoma patients.
4/2013	Low cyclin F expression in hepatocellular carcinoma associates with poor differentiation and unfavorable prognosis.
1/2013	Protection of renal impairment by angiotensin II type 1 receptor blocker in rats with post-infarction heart failure.
9/2012	High expression of trimethylated histone H3 lysine 4 is associated with poor prognosis in hepatocellular carcinoma.
4/2011	Loss/Down-regulation of tumor suppressor in lung cancer 1 expression is associated with tumor progression and is a biomarker of poor prognosis in ovarian carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Muyan Cai Research Topics

Disease

20	Neoplasms (Cancer) 01/2023 - 04/2011
10	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2012
6	Carcinoma (Carcinomatosis) 01/2023 - 04/2011
5	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 03/2016
4	Esophageal Squamous Cell Carcinoma 01/2023 - 11/2015
4	Neoplasm Metastasis (Metastasis) 09/2021 - 03/2014
3	Carcinogenesis 12/2017 - 01/2012
2	Fibrosis (Cirrhosis) 03/2017 - 01/2013
2	Necrosis 02/2015 - 01/2013
1	Glioma (Gliomas) 05/2024
1	Urachal cancer 01/2022
1	Stomach Neoplasms (Stomach Cancer) 01/2022
1	Inflammation (Inflammations) 12/2017
1	Nasopharyngeal Carcinoma 12/2017
1	Chromosomal Instability (Chromosome Stability) 12/2017
1	Malignant Mesothelioma 01/2017
1	Adenocarcinoma 06/2016
1	Pathologic Complete Response 06/2016
1	Endometrial Neoplasms (Endometrial Cancer) 08/2014
1	Lymphoma (Lymphomas) 08/2014
1	Genomic Instability 04/2013
1	Infarction (Infarctions) 01/2013
1	Heart Failure 01/2013
1	Cardio-Renal Syndrome 01/2013
1	Liver Neoplasms (Liver Cancer) 09/2012

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 12/2017 - 04/2011
6	Biomarkers (Surrogate Marker)IBA 10/2021 - 04/2011
4	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2021
3	Messenger RNA (mRNA)IBA 10/2014 - 04/2013
2	130-nm albumin-bound paclitaxelIBA 01/2023 - 08/2021
2	camrelizumabIBA 01/2023 - 08/2021
2	B7-H1 AntigenIBA 01/2023 - 01/2021
2	Cadherins (E-Cadherin)IBA 09/2021 - 03/2014
2	MicroRNAs (MicroRNA)IBA 05/2018 - 08/2014
1	Hematoxylin (Haematoxylon)IBA 05/2024
1	Eosine Yellowish-(YS) (Eosin)IBA 05/2024
1	Capecitabine (Xeloda)FDA Link 01/2023
1	KinesinsIBA 10/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 10/2021
1	CateninsIBA 10/2021
1	Capsules (Microcapsules)IBA 08/2021
1	Aldehyde DehydrogenaseIBA 01/2021
1	EnzymesIBA 05/2018
1	Phosphoglycerate Mutase (Phosphoglyceromutase)IBA 01/2018
1	Fluorouracil (Carac)FDA LinkGeneric 01/2018
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2018
1	Mitochondrial DNA (mtDNA)IBA 12/2017
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 12/2017
1	Surface Antigens (Surface Antigen)IBA 03/2017
1	AfatinibIBA 01/2017
1	CrizotinibIBA 01/2017
1	AsbestosIBA 01/2017
1	Carrier Proteins (Binding Protein)IBA 01/2017
1	ElementsIBA 01/2017
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2017
1	endonuclease GIBA 04/2016
1	K Cl- CotransportersIBA 04/2016
1	Apoptosis Inducing FactorIBA 04/2016
1	Metalloproteases (Metalloproteinases)IBA 04/2016
1	Fibronectins (Fibronectin)IBA 04/2016
1	HexokinaseIBA 03/2016
1	PhosphoproteinsIBA 02/2015
1	TNF Receptor-Associated Factor 2 (TRAF2)IBA 02/2015
1	Receptor-Interacting Protein Serine-Threonine KinasesIBA 02/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2014
1	Cysteine (L-Cysteine)FDA Link 08/2014
1	Cysteine-Rich Protein 61IBA 08/2014
1	Progesterone Receptors (Progesterone Receptor)IBA 04/2014
1	Estrogens (Estrogen)FDA Link 04/2014
1	Transcription Factors (Transcription Factor)IBA 04/2014
1	Small Interfering RNA (siRNA)IBA 03/2014
1	CyclinsIBA 04/2013
1	Ligases (Synthetase)IBA 04/2013
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 04/2013
1	UbiquitinIBA 04/2013
1	NitrogenIBA 01/2013
1	CreatinineIBA 01/2013
1	Urea (Carbamide)FDA LinkGeneric 01/2013
1	Angiotensin IIIBA 01/2013
1	Losartan (Cozaar)FDA LinkGeneric 01/2013
1	Type 1 Angiotensin ReceptorIBA 01/2013
1	Angiotensin II Type 1 Receptor BlockersIBA 01/2013
1	Cystatin CIBA 01/2013
1	Histone MethyltransferasesIBA 09/2012
1	histone H3 trimethyl Lys4IBA 09/2012
1	Histones (Histone)IBA 09/2012
1	Lysine (L-Lysine)FDA Link 09/2012
1	Fetal Proteins (Fetoprotein)IBA 01/2012
1	Phosphotransferases (Kinase)IBA 01/2012
1	SirtuinsIBA 01/2012
1	Sirtuin 3IBA 01/2012
1	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2012
1	NAD (NADH)IBA 01/2012
1	Adenine NucleotidesIBA 01/2012

Therapy/Procedure

7	Immunotherapy 10/2022 - 01/2021
4	Therapeutics 01/2019 - 08/2014
3	Drug Therapy (Chemotherapy) 01/2023 - 01/2018
3	Neoadjuvant Therapy 01/2023 - 11/2015
2	Esophagectomy 08/2021 - 11/2015
1	VAP-cyclo protocol 01/2012